Clinical Trials

42 enrolled

HR Positive/HER-2 Negative Breast Cancer

NCT05143970 2024-03-20

CHANCES

BreastGastrointestinalGynecologicThoracic

27 enrolled

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04961632 2024-02-01

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

75 enrolled

Breast Neoplasms

NCT05673694 2023-12-14

To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.

70 enrolled

Breast Neoplasms

NCT06149611 2023-11-29

Mass Balance Study of TQB3616

8 enrolled

Breast Neoplasms

NCT02915445 2023-11-22

EpCAM CAR-T for Treatment of Advanced Solid Tumors

BreastGastrointestinalHead & NeckOther neoplasm

Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

BreastGynecologicOther solid neoplasmThoracic

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03129139 2023-10-18

Minnelide 101

66 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms

NCT06065592 2023-10-06

CAT_PB

BreastGastrointestinalGenitourinaryThoracic

500 enrolled

Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Carcinoma, Hepatocellular, Immune System Diseases, Inflammation, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Thromboembolism, Thrombosis

NCT06047184 2023-09-21

Phase I Study of BEBT-209 in Women With Advanced Breast Cancer

106 enrolled

Advanced Breast Cancer

NCT05957939 2023-07-24

Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

2 enrolled

Triple Negative Breast Neoplasms

NCT05955833 2023-07-21

HER Image

6 enrolled

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT05780307 2023-06-07

IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors

BreastGastrointestinalThoracic

48 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT05177432 2023-04-18

QUEST

26 enrolled

Breast Neoplasms

NCT05755581 2023-03-06

Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in Breast Cancer Patients

100 enrolled

Female Breast Cancer

NCT04768868 2023-02-24

WEE1

BreastGastrointestinalGenitourinaryGynecologic

350 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05738993 2023-02-22

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

100 enrolled

Breast Neoplasms

NCT05692661 2023-01-20

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

24 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03775525 2022-12-23

GEN602

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

127 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT00986661 2022-11-02

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

BreastDermatologicEndocrineGastrointestinalThoracic

78 enrolled

Uveal Melanoma, Breast Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05586841 2022-10-19

Exploration of Dalpiciclib + Chidamide in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor: a Phase Ⅰb Study

HR+/HER2- Advanced Breast Cancer

NCT03720431 2022-08-17

TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer

11 enrolled

Triple Negative Breast Neoplasms

NCT05504213 2022-08-17

A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer

224 enrolled

Breast Neoplasms

NCT03934827 2022-08-11

MICROBIOME

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

120 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Uterine Neoplasms

NCT03788083 2022-05-19

TMBA

36 enrolled

Breast Neoplasms

NCT05365204 2022-05-09

A Study for Optimization of 6% Hydroxyethyl Starch Based Indocyanine Green Near-infrared Fluorescence Navigated Sentinel Lymph Node Biopsy for Breast Cancer Patients

24 enrolled

Breast Neoplasms

NCT03251313 2022-04-20

PD-1(Programmed Death-1) Antibody +GP as First Line Treatment for Triple Negative Breast Cancer(TNBC) Patients

31 enrolled

Triple Negative Breast Neoplasms

NCT02637531 2022-04-04

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549

BreastDermatologicEndocrineOther solid neoplasmThoracic

219 enrolled

Carcinoma, Non-Small-Cell Lung, Melanoma, Mesothelioma, Adrenocortical Carcinoma, Triple Negative Breast Neoplasms

NCT05274893 2022-03-11

A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer

28 enrolled

Advanced Breast Cancer

NCT05273944 2022-03-10

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

80 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT05251766 2022-02-23

Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer

Breast Neoplasms

NCT02626507 2022-02-09

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

18 enrolled

Breast Neoplasms

NCT03847168 2021-11-17

KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer

22 enrolled

Breast Neoplasms

NCT04993430 2021-11-16

A Phase 1 Study of HRS8807 Monotherapy and in Combination With SHR6390 in Subjects With ER-Positive, HER2-Negative Metastatic or Locally Advanced Breast Cancer

90 enrolled

ER-Positive, HER2-Negative Breast Cancer

NCT03552406 2021-05-06

Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

33 enrolled

BreastHead & Neck

Breast Neoplasms, Head and Neck Neoplasms

NCT04856371 2021-04-23

Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+, HER2- Advanced Breast Cancer

228 enrolled

Advanced Breast Cancer

NCT04142931 2021-03-24

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT04764084 2021-02-21

Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors

52 enrolled

BreastGastrointestinal

Breast Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT03749850 2021-02-17

i-GO

12 enrolled

Hyperthermia, Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT03125746 2021-01-05

A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors

72 enrolled

Advanced Breast Cancer

NCT04091958 2020-11-19

Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap.

15 enrolled

Breast Neoplasms

NCT04427215 2020-06-11

Complementary and Alternative Medicine on Mental Health in Breast Cancer Patients

250 enrolled

Breast Neoplasms

NCT04107142 2019-09-27

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

BreastGastrointestinalGenitourinaryHead & NeckSarcoma

10 enrolled

Nasopharyngeal Carcinoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT03583125 2019-09-11

Study of EOC317 in Chinese Patients With Advanced Solid Tumors

BreastGastrointestinalGenitourinary

140 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Cholangiocarcinoma

NCT03850873 2019-02-22

A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics

Advanced Breast Cancer

NCT02950064 2019-01-14

A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations

BreastGastrointestinalGenitourinaryGynecologic

95 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

NCT03487055 2018-04-03

Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

Breast Neoplasms

NCT03076372 2018-02-27

A Study Evaluating MM-310 in Patients With Solid Tumors